Form D · Venture Capital Fund
TCGX Asia Life Sciences Fund I, L.P.
Palo Alto, CA · CIK 0002140843
Offering snapshot reported Oct 7, 2026 · SEC filing
- Reported sold
- $600M Offering amount: $600M
- Investors reported
- 70 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 70
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2026 | Amendment | $600,000,000 | No comparison | 70 | SEC filing |
| Jul 29, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592516
Source: Form D, filed Oct 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chen Yu | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
245 Lytton Ave., Suite 350
Palo Alto, CA, 94301
Palo Alto, CA, 94301